(2R,3R)-3-(tert-Butyl)-2-isopropyl-4-(2-methoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole, 95.00%, 500mg

3-Fluoro-5-formylbenzonitrile, 95.0%, 100g

3-(Morpholin-4-ylmethyl)benzoic acid, 97.0%, 5g

2-Chloro-N-phenylisonicotinamide, 95.0%, 5g

Methyl 1,3-Thiazole-5-carboxylate, 97.0%, 10g

3-Iodo-1-(tetrahydro-pyran-2-yl)-1H-pyrazole-4-carbaldehyde, 95.0%, 1g

Récipient de réaction à bride plate cylindrique, gradué (2) Fond plat, DN 150, 250 mm, Hauteur, 630 mm, 1 Pièce

N,N-Dimethyl-2-nitroethenamine, 98%, 1g

2-((tert-Butoxycarbonyl)(pentyl)amino)acetic acid, 95%, 500mg

4-(4-Methylpiperazin-1-yl)-2-(4-methylpiperidin-1-yl)aniline, 95%, 1g

5-(2-Nitrophenyl)isoxazole-3-carboxylic acid, 95.0%, 100mg

tert-butyl [cis-3-(aminomethyl)cyclohexyl]carbamate, 95.0%, 1g

2'-Hydroxy-5'-isopropyl acetophenone, 97.0%, 5g